Abstract
Substantial progress has been made in the past year in identifying new primary disorders associated with abnormalities of purine and pyrimidine metabolism, in defining more precisely the metabolic consequences of specific enzyme defects, and in deducing the mechanisms involved in producing their clinical expression. A new primary cause of purine overproduction has been identified in children with a type of genetically determined immunodeficiency disease involving a primary T-cell dysfunction (Cohen et al., 1976; Wadman et al., 1977; Stoop et al., 1977). The condition, however, presents a curious metabolic paradox. Although the children overproduce purines, they produce virtually no uric acid and so can be conveniently identified by their marked hypouricemia and hypour-icuria. The resolution of the paradox is found in the metabolic site of their enzyme deficiency—a gross deficiency of the enzyme purine nucleoside Phosphorylase (PNP), which is responsible for processing purine ribosides to their free purine bases. As a consequence, the ribosides inosine and guanosine and the corresponding deoxyribosides replace uric acid as the end products of purine metabolism and are produced in a remarkable abundance quite comparable to the record degree of purine overproduction excreted as uric acid by children with the Lesch-Nyhan syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackeret, C., Plüss, H. J., and Hitzig, W. H., 1976, Hereditary severe combined immunodeficiency and adenosine deaminase deficiency, Pediatr. Res. 10:67–70.
Adams, A., and Harkness, R. A., 1976a, Adenosine deaminase activity in thymus and other human tissues, Clin. Exp. Immonol. 26:647–649.
Adams, A., and Harkness, R. A., 1976b, Developmental changes in purine phos-phoribosyltransferases in human and rat tissues, Biochem. J. 160:565–576.
Adamson, R. H., Zaharevitz, D. W., and Johns, D. G., 1977, Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2′-deoxycoformycin, Pharmacology 15:84–89.
Agarwal, R. P., Crabtree, G. W., Parks, R. E., Jr., Nelson, J. A., Keightley, R., Parkman, R., Rosen, F. S., Stern, R. C., and Polmar, S. H., 1976, Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency, J. Clin. Invest. 57:1025–1035.
Alford, B. L., and Barnes, E. M., Jr., 1976, Hypoxanthine transport by cultured Chinese hamster lung fibroblasts, J. Biol. Chem. 251:4823–4827.
Allison, A. C., Hovi, T., Watts, R. W. E., and Webster, A. D. B., 1975, Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de novo purine synthesis in lymphocyte transformation, Lancet 2:1179–1183.
Allison, A. C., Hovi, T., Watts, R. W. E., and Webster, A. D. B., 1977, The role of de novo purine synthesis in lymphocyte transformation, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 207–224, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Anderson, L. T., Herrmann, L., and Daneis, J., 1976, The effect of L-5-hydroxy-tryptophan on self-mutilation in Lesch-Nyhan disease: A negative report, Neuropaediatrie 7:439–442.
Anderson, L., Dancis, J., Alpert, M., and Herrmann, L., 1977, Punishment learning and self-mutilation in Lesch-Nyhan disease, Nature (London) B 265:461–463.
Arnold, W. J., and Kelley, W. N., 1975, Studies on the electrophoretic variants of human hypoxanthine-guanine phosphoribosyltransferase, in: Isozymes I: Physiological Function, pp. 213–225, Academic Press, New York.
Astrin, K., 1973, Purine metabolism in cultured human lymphoid cells, Ph.D. thesis Department of Biology, University of California, San Diego, California.
Bakay, B., and Nyhan, W. L., 1975, Heterogeneity of hypoxanthine-guanine phosphoribosyl transferase from human erythrocytes, Arch. Biochem. Biophys. 168:26–34.
Bakay, B., Becker, M. A., and Nyhan, W. L., 1976, Reaction of antibody to normal human hypoxanthine phosphoribosyltransferase with products of mutant genes, Arch. Biochem. Biophys. 177:415–426.
Bakay, B., Francke, U., Nyhan, W. L., and Seegmiller, J. E., 1977a, Experience with detection of heterozygous carriers and prenatal diagnosis of Lesch-Nyhan disease, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 351–358, Plenum Press, New York.
Bakay, B., Graf, M., Carey, S., and Nyhan, W. L., 1977b, Study of immunoreactive material in patients with deficient HPRT activity, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 361–369, Plenum Press, New York.
Balis, M. E., 1976, Uric acid metabolism in man, Adv. Clin. Chem. 18:213–246.
Ballet, J.-J., Insel, R., Merler, E., and Rosen, F. R., 1976, Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase, J. Exp. Med. 143:1271–1276.
Beaudry, M. A., Letarte, J., Collu, R., Leboeuf, G., Ducharme, J. R., Melancon, S. B., and Dallairf, L., 1975, Chronic hyperammonemia with orotic aciduria: Evidence of pyrimidine pathway stimulation (author’s transi.), Diabete Metab. 1:29–37.
Becker, M. A., 1976a, Regulation of purine nucleotide synthesis: Effects of inosine on normal and hypoxanthine-guanine phosphoribosyltransferase-deficient fibroblasts, Biochim. Biophys. Acta 435:132–144.
Becker, M. A., 1976b, Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction, J. Clin. Invest. 57:308–318.
Becker, M. A., 1977a, Fibroblast phosphoribosylpyro phosphate and ribose-5-phosphate concentration and generation in gout with purine overproduction, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 270–279, Plenum Press, New York.
Becker, M. A., 1977b, Effects of inosine on purine synthesis in normal and HGPRT-deficient fibroblasts, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 370–375, Plenum Press, New York.
Becker, M. A., and Seegmiller, J. E., 1975, Recent advances in the identificaron of enzyme abnormalities underlying excessive purine synthesis in man, Arthritis Rheum. 18(Suppl.):687–694.
Becker, M. A., Meyer, L. J., and Seegmiller, J. E., 1973, Gout with purine overproduction due to increased phosphoribosylpyrophosphate synthetase activity, Am. J. Med. 55:232–242.
Becker, M. A., Kostel, P. J., and Meyer, L. J., 1975, Human phosphoribosylpyro-phosphate synthetase: Comparison of purified normal and mutant enzymes, J. Biol. Chem. 250:6822–6830.
Becker, M. A., Meyer, L. J., Huisman, W. H., Lazar, C. S., and Adams, W. B., 1977, Human phosphoribosylpyrophosphate synthetase: Relation of activity and quaternary structure, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 71–79, Plenum Press, New York.
Ben-Bassat, I., Brok-Simoni, F., Kende, G., Holtzmann, F., and Ramot, B., 1976, A family with red cell pyrimidine 5′-nucleotidase deficiency, Blood 47:919–922.
Benjamin, D., Sperling, O., Weinberger, A., Pinkas, J., and deVries, A., 1977, Familial renal hypouricemia due to isolated tubular defect, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 72–76, Plenum Press, New York.
Benke, P. J., and Dittmar, D., 1976, Purine dysfunction in cells from patients with adenosine deaminase activity, Pediatr. Res. 10:642–646.
Benke, P. J., and Gold, S., 1977, Purine metabolism in therapy of von Gierke’s disease, Pediatr. Res. 11:511 (abstract).
Bergsma, D. (ed.), 1975, Immunodeficiency in Man and Animals; Birth Defects, Vol. II, Sinauer Associates, Sunderland, Massachusetts.
Bloch, A., 1973, The design of biologically active nucleosides, in: Drug Design, Vol. IV (E. J. Ariens, ed.), pp. 285–378, Academic Press, New York.
Bogusky, R. T., Lowenstein, L. M., and Lowenstein, J. M., 1976, The purine nucleotide cycle: A pathway for ammonia production in the rat kidney, J. Clin. Invest. 58:326–335.
Brady, T. G., and O’Donovan, C. I., 1965, A study of the tissue distribution of adenosine deaminase in six mammal species, Comp. Biochem. Physiol. 14:101–120.
Breakefield, X. O., Castiglione, C. M., and Edelstein, S. B., 1976, Monoamine oxidase activity decreased in cells lacking hypoxanthine phosphoribosyltrans-ferase activity, Science 192:1018–1020.
Brenton, D. P., Astrin, K. H., Cruikshank, M. K., and Seegmiller, J. E., 1977, Measurement of free nucleotides in cultured human lymphoid cells using high-pressure liquid chromatography, Biochem. Med. 17:231–247.
Broom, B. C., De la Concha, E. G., Webster, A. D. B., Janossy, G. J., and Asherson, G. L., 1976, Intracellular immunoglobulin production in vitro by lymphocytes from patients with hypogammaglobulinemia and their effect on normal lymphocytes, Clin. Exp. Immunol. 23:73–77.
Brosh, S., Boer, P., Kupfer, B., deVries, A., and Sperling, O., 1976, De novo synthesis of purine nucleotides in human peripheral blood leukocytes: Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransfer-ase deficiency, J. Clin. Invest. 58:289–297.
Buckley, R. H., Gilbertsen, R. B., Schiff, R. I., Ferreira, E., Sanai, S. O., and Waldmann, T. A., 1976, Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency: Evidence against a stem cell defect, J. Clin. Invest. 58:130–136.
Burnstock, G., 1977, The purinergic nerve hypothesis, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 295–314, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Carson, D. A., and Seegmiller, J. E., 1976, Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis, J. Clin. Invest. 57:274–282.
Carson, D. A., Goldblum, R., Keightley, R., and Seegmiller, J. E., 1977a, Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 463–470, Plenum Press, New York.
Carson, D. A., Goldblum, R., and Seegmiller, J. E., 1977b, Quantitative immunoassay of adenosine deaminase in combined immunodeficiency disease, J. Immunol. 118:270–273.
Cartier, M. P., and Hamet, M., 1974, A new metabolic disease: The complete deficit of adenine phosphoribosyltransferase and lithiasis of 2,8-dihydroxy-adenine, C. R. Acad. Sci. (Paris) 279:883–886.
Catel, V. W., and Schmidt, J., 1959, Über familiare gichtische Diathese in Verbindung mit zerebralen und renalen Symptomen bei einem Kleinkind, Deutsch. Med. Wochenschr. 84:2145–2147.
Cederbaum, S.D., Kaitila, I., Rimoin, D. L., and Stiehm, E. R., 1976, The chondroosseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency, J. Pediatr. 89:737–742.
Chalmers, R. A., 1975, Crystals in skeletal muscle in xanthinuria and in allopurinol-treated gout patients, S. Afir. Med. J. 49:2072.
Chambers, D. A., Martin, D. W., and Weinstein, Y., 1974, The effect of cyclic nucleotides on purine biosynthesis and the induction of PRPP synthetase during lymphocyte activation, Cell 3:375–380.
Chassin, M. M., Chirigos, M. A., Johns, D. G., and Adamson, R. H., 1977, Adenosine deaminase inhibition for immunosuppression, N. Engl. J. Med. 296:1232.
Chen, S.-H., Scott, C. R., and Swedberg, K. R., 1975, Heterogeneity for adenosine deaminase deficiency: Expression of the enzyme in cultured skin fibroblasts and amniotic fluid cells, Am. J. Hum. Genet. 27:46–52.
Ciba Foundation Symposium No. 48: Purine and Pyrimidine Metabolism, 1977, Elsevier/ Excerpta Medica and North-Holland, Amsterdam and New York.
Clark, R. B., and Seney, M. N., 1976, Regulation of adenylate cyclase from cultured human cell lines by adenosine, J. Biol. Chem. 251:4239–4246.
Clifford, A. J., Steine, L., and Castles, J. J., 1977, Activities of purine pathway enzymes in gouty human fibroblasts aged in vitro, Clin. Chim. Acta 74:255–260.
Cohen, A., and Martin, D. W., Jr., 1977, Inosine uptake by cultured fibroblasts from normal and purine nucleoside Phosphorylase deficient humans, J. Biol. Chem. 252:4428–4430.
Cohen, A., Doyle, D., Martin, D. W. Jr., and Ammann, A. J., 1976, Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside Phosphorylase, N. Engl. J. Med. 295:1449–1454.
Cohen, A., Ammann, A. J., Staal, G. E. J., Borkowsky, W., Hirschhorn, R., and Martin, D. W., Jr., 1977a, Purine, pyrimidine and pyridine nucleotide levels in erythrocytes of purine nucleoside Phosphorylase and adenosine deaminase deficient patients (personal communication).
Cohen, A., Staal, G. E. J., Stoop, J. W., Ammann, A. J., and Martin, D. W., Jr., 1977b, Orotic aciduria in two patients with inherited deficiencies of purine nucleoside Phosphorylase, J. Clin. Invest. 60:491–494.
Conger, J. D., Falk, S. A., Guggenheim, S. J., and Burke, T. J., 1976, A micropuncture study of the early phase of acute urate nephropathy, J. Clin. Invest. 58:681–689.
Daddona, P. E., and Kelley, W. N., 1977a, Human adenosine deaminase: Purification and subunit structure, J.Biol. Chem. 252:110–115.
Daddona, P. E., and Kelley, W. N., 1977b, Purification of human erythrocyte adenosine deaminase, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 223–234, Plenum Press, New York.
Debray, H., Cartier, P., Temstet, A., and Cendron, J., 1976, Child’s urinary lithiasis revealing a complete deficit in adenine phosphoribosyltransferase, Pediatr. Res. 10:762–766.
deBruyn, C. H., 1976, Hypoxanthine-guanine phosphoribosyltransferase deficiency, Hum. Genet. 31:127–150.
Degnen, G. E., Miller, I. L., Eisenstadt, J. M., and Adelberg, E. A., 1976, Chromosome-mediated gene transfer between closely related strains of cultured mouse cells, Proc. Natl. Acad. Sci. U.S.A. 73:2838–2843.
deVries, A., and Sperling, O., 1976, Uric acid stone formation: Basic concepts of aetiology and treatment, in: Scientific Foundations of Urology, Vol. I (D. I. Williams and G. D. Chisholm, eds.), pp. 297–302, William Heinemann Medical Books, London.
deVries, A., and Sperling, O., 1977, Implications of disorders of purine metabolism for the kidney and the urinary tract, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 179–206, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Dietz, A. A., and Czebotar, V., 1977, Purine metabolic cycle in normal and leukemic leukocytes, Cancer Res. 37:419–426.
Elion, G., 1977 (personal communication).
Emmerson, B. T., and Row, P. G., 1975, An evaluation of the pathogenesis of the gouty kidney (editorial), Kidney Int. 8:65–71.
Emmerson, B. T., Gordon, R. B., and Johnson, L. A., 1976, Urate kinetics in hypoxanthine-guanine phosphoribosyltransferase deficiency: Their significance for the understanding of gout, Q. J. Med. 45:49–61.
Emmerson, B. T., Johnson, L. A., and Gordon, R. B., 1977, HGPRT-positive and HGPRT-negative erythrocytes in heterozygotes for HGPRT deficiency, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 359–360, Plenum Press, New York.
Eriksson, B., Helgstrand, E., Johannsson, N. G., Larsson, A., Misiorny, A., Noren, J. O., Philipson, L., Stenberg, K., Stening, G., Stridh, S., Oberg, B., 1977, Inhibition of influenza virus RNA polymerase by ribavirin triphosphate, Antimicrob. Agents Chemother. 11:946–951.
Fischer, D., Van der Weyden, M. B., Snyderman, R., and Kelley, W. N., 1976, A role of adenosine deaminase in human monocyte maturation, J. Clin. Invest. 58:399–407.
Fleisch, H., Robertson, W. G., Smith, L. H., and Vahlensieck, W. (eds.), 1976, Urolithiasis Research, Plenum Press, New York, 582 pp.
Fox, I. H., and Marchant, P. J., 1976, Purine catabolism in man: Characterization of placental microsomal 5′-nucleotidase, Can. f. Biochem. 54:462–469.
Fox, I. H., and Marchant, P., 1977, Human 5′-nucleotidase: Multiple molecular forms and regulation, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 249–253, Plenum Press, New York.
Francke, U., Felsenstein, J., Gartler, S. M., Migeon, B. R., Dancis, J., Seegmiller, J. E., Bakay, B., and Nyhan, W. L., 1976, The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease, Am. J. Hum. Genet. 28:123–137.
Frank, O., 1977, Nutritional state and purine metabolism, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 266–268, Plenum Press, New York.
Frith, C. D., Johnstone, E. C., Joseph, M. H., Powell, R. J., and Watts, R. W. E., 1976, Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome, J. Neurol. Neurosurg. Psychiatry 39:656–662.
Giblett, E. R., Ammann, A. J., Wara, D. W., Sandman, R., and Diamond, L. K., 1975, Nucleoside Phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity, Lancet 1:1010–1013.
Glynn, J. J., and Clayton, M. L., 1976, Sparing effect of hemiplegia on tophaceous gout, Ann. Rheum. Dis. 35:534–535.
Goldblum, R. C., 1977 (personal communication).
Goldblum, R. C., Schmalstieg, F. C., Goldman, A. S., Nelson, J. A., and Monahan, T. M., 1976, Abnormal adenine metabolism in severe combined immunodeficiency (SCID) and normal adenosine deaminase (ADA) activity, Pedialr. Res. 10:387.
Graf, L. H., Jr., McRoberts, J. A., Harrison, T. M., and Martin, D. W., Jr., 1976, Increased PRPP synthetase activity in cultured rat hepatoma cells containing mutations in the hypoxanthine-guanine phosphoribosyltransferase gene, J. Cell Physiol. 88:331–342.
Green, H., 1975, Pyrimidine starvation induced by adenosine in cultured cells and its bearing on the lymphocyte deficiency disease associated with absence of adenosine deaminase, in: Combined Immunodeficiency Disease and Adenosine Deaminase Deficiency: A Molecular Defect (H. J. Meuwissen, R. J. Pickering, B. Pollara, and I. H. Porter, eds.), pp. 141–155, Academic Press, New York.
Greene, H. L., Slonim, A. E., O’Neill, J. A., Jr., and Burr, I. M., 1976, Continuous nocturnal intragastric feeding for management of Type I glycogen-storage disease, N. Engl J. Med. 294:423–425.
Gusella, J. F., and Housman, D., 1976, Induction of erythroid differentiation in vitro by purines and purine analogues, Cell 8:263–269.
Hadden, J. W., Hadden, E. M., and Coffey, R. G., 1976a, Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation, Infect. Immun. 13:382–387.
Hadden, J. W., Hadden, E. M., Sadlik, J. R., and Coffey, R. G., 1976b, Effects of concanavalin A and succinylated derivatives on lymphocyte proliferation and cyclic nucleotide levels, Proc. Natl. Acad. Sci. U.S.A. 73:1717–1721.
Hamet, M., Griscelli, C., Cartier, P., Ballay, J., deBruyn, C., and Hoslie, P., 1977, A second case of inosine Phosphorylase deficiency with severe T-cell abnormalities, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 477–480, Plenum Press, New York.
Henderson, J. F., 1977, Inosine triphosphate metabolism in human erythrocytes, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 115–120, Plenum Press, New York.
Henderson, J. F., and Battell, M. L., 1976, Short communications: Metabolic effects of ethyl adenosine 5′-car boxylate in Ehrlich ascites tumor cells in vitro, Biochem. Pharmacol 25:1915–1916.
Henderson, J. F., Dossetor, J. B., Dasgupta, M. K., and Russel, A. S., 1976, Uric acid lithiasis associated with altered kinetics of hypoxanthine-guanine phosphoribosyltransferase, Clin. Biochem. 9:4–8.
Henderson, J. F., Lowe, J. K., and Barankiewicz, J., 1977, Purine and pyrimidine metabolism: Pathways, pitfalls and perturbations, in: Ciba Found. Symp. No. 48: Purine and Pyrimiáne Metabolism, pp. 3–22, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Hershfield, M. S., and Seegmiller, J. E., 1976, Regulation of de novo purine biosynthesis in human lymphoblasts: Coordinate control of proximal (rate-determining) steps and the inosinic acid branch point, J. Biol. Chem. 251:7348–7354.
Hershfield, M. S., and Seegmiller, J. E., 1977a, Regulation of de novo purine synthesis in human lymphoblasts: Similar rates of de novo synthesis during growth by normal cells and mutants deficient in hypoxanthine-guanine phosphoribosyltransferase activity, J. Biol. Chem. (in press).
Hershfield, M. S., and Seegmiller, J. E., 1977b, Coordinate regulation of the proximal and distal steps of the pathway of purine synthesis de novo in W1-L2 human lymphoblasts, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, J. E. Seegmiller, eds.), pp. 19–29, Plenum Press, New York.
Hershfield, M. S., Snyder, F., and Seegmiller, J. E., 1977a, Adenine and adenosine are toxic to human lymphoblast mutants deficient in adenine phosphoribosyl-transferase or adenosine kinase, Science 197:1284–1286.
Hershfield, M. S., Spector, E. B., and Seegmiller, J. E., 1977b, Purine synthesis and excretion in mutants of the W1-L2 human lymphoblastoid line deficient in adenosine kinase (AK) and adenine phosphoribosyltransferase (APRT), in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 303–313, Plenum Press, New York.
Hirschhorn, R., 1977 (personal communication).
Hirschhorn, R., Beratis, N., Rosen, F. S., Parkman, R., Stern, R., and Polmar, S., 1975, Adenosine-deaminase deficiency in a child diagnosed prenatally, Lancet 1:73–75.
Hirschhorn, R., Beratis, N., and Rosen, F. S., 1976, Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: Evidence for a mutant enzyme, Proc. Natl Acad. Sci. U.S.A. 73:213–217.
Holland, M.J. C., DiLorenzo, A. M., Daneis, J., Balis, M. E., Yü, T.-F., and Cox, R. P., 1976a, Hypoxanthine phosphoribosyltransferase activity in intact fibroblasts from patients with X-linked hyperuricemia, J.Clin. Invest. 57:1600–1605.
Holland, M. J. C., Klein, N. C., Cox, R. P., Daneis, J., Yü, T.-F., Salser, J. S., and Balis, M. E., 1976b, Purine excretion by cultured skin fibroblasts from patients with abnormal purine metabolism, Res. Commun. Chem. Pathol. Pharmacol. 14:331–342.
Holmes, E. W., Jr., Mason, D. H., Jr., Goldstein, L. I., Blount, R. E., Jr., and Kelley, W. N., 1974, Xanthine oxidase deficiency: Studies of a previously unreported case, Clin. Chem. 20:1076–1079.
Holmes, E. W., Kelley, W. N., and Wyngaarden, J. B., 1975–1976, Control of purine biosynthesis in normal and pathologic states, Bull. Rheum. Dis. 26:848–853.
Hovi, T., Smyth, J. F., Allison, A. C., and Williams, S. C., 1976, Role of adenosine deaminase in lymphocyte proliferation, Clin. Exp. Immunol. 23:395–403.
Hovi, T., Allison, A. C., Raivio, K. O., and Vaheri, A., 1977, Purine metabolism and control of cell proliferation, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 225–248, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Hsu, H. H. T., 1975, Specific adenosine binding proteins from rat liver (38882), Proc. Soc. Exp. Biol. Med. 149:698–701.
Isaacs, H., Heffron, J. J. A., Berman, L., Badenhorst, M., and Pickering, A., 1975, Xanthine, hypoxanthine and muscle pain: Histochemical and biochemical observations, S. Afir. Med. J. 49:1035–1038.
Ito, K., and Uchino, H., 1976, Control of pyrimidine biosynthesis in human lymphocytes: Inhibitory effect of guanine and guanosine on induction of enzymes for pyrimidine biosynthesis de novo in phytohemagglutinin-stimulated lymphocytes, J. Biol Chem. 251:1427–1430.
Jacobs, D., 1977, Hyperuricemia as a risk factor in coronary heart disease, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 231–237, Plenum Press, New York.
Jenkins, R., Rabson, A. R., Nurse, G. T., Lane, A. B., and Hopkinson, D. A., 1976, Deficiency of adenosine deaminase not associated with severe combined immunodeficiency, J. Pediatr. 89:732–736.
Johns, D. G., and Adamson, R. H., 1976, Enhancement of the biological activity of cordycepin (3′-deoxyadenosine) by the adenosine deaminase inhibitor 2′-deoxycoformycin, Biochem. Pharmacol 25:1441–1444.
Johnson, S. M., Asherson, G. L., Watts, R. W. E., North, M. E., Allsop, J., and Webster, A. D. B., 1977, Lymphocyte-purine 5′-nucleotidase deficiency in primary hypogammaglobulinemia, Lancet 1:168–170.
Kahan, B., and DeMars, R., 1975, Localized derepression on the human inactive X chromosome in mouse-human cell hybrids, Proc. Natl Acad. Sci. U.S.A. 72:1510–1514.
Kaufman, J. M., Greene, M. L., and Seegmiller, J. E., 1968, Urine uric acid to creatinine ratio: A screening test for inherited disorders of purine metabolism, J. Pediatr. 73:583–592.
Keightley, R. G., Lawton, A. R., Cooper, M. D., and Yunis, E. J., 1975, Successful fetal liver transplantation in a child with severe combined immunodeficiency, Lancet 2:850–883.
Kelley, W. N., 1975, Effect of drugs on uric acid in man, Annu. Rev. Pharmacol. 15:327–350.
Kelley, W. N., 1976, Current therapy of gout and hyperuricemia, Hosp. Pract. 11:69–76.
Kenawi, M. M., 1976, Xanthinuria and xanthine calculous pyonephrosis, J. R. Coll. Surg. Edinburgh 21:95–99.
Kitamura, T., Kawamura, T., Kitagawa, R., and Ogawa, A., 1976, Xanthine stone and xanthinuria associated with retrocaval ureter: Report of a case and a review of the literature (author’s transl.), Jpn. J. Urol 67:670–676.
Klassen, L. W., Budman, D. R., Williams, G. W., Steinberg, A. D., and Gerber, N. L., 1977, Ribavirin efficacy in the treatment of murine autoimmune disease, Science 195:787–789.
Klinenberg, J. R. (ed.), 1975, Proceedings of the Second Conference on Gout and Purine Metabolism, Arthritis Rheum. (Suppl.): 18:659–893.
Klinenberg, J. R., Campion, D. S., Olsen, R. W., Caughey, D., and Bluestone, R., 1977a, A relationship between free urate, protein-bound urate, hyperuricemia and gout in Caucasians and Maoris, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 159–162, Plenum Press, New York.
Klinenberg, J. R., Bluestone, R., and Waisman, J., 1977b, Suppression of experimental urate nephropathy by salicylate, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 176–178, Plenum Press, New York.
Kozin, F., Ginsberg, M., Karasek, V., Skosey, J., and McCarty, D., 1977, Protein binding to monosodium urate crystals and its effect on platelet degranulation, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 201–208, Plenum Press, New York.
Kwong, L. K., and Tsuboi, K. K., 1977, Selective inhibition-of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36:774 (abstract).
Lewis, A. S., 1977, Purine nucleoside Phosphorylase of rabbit liver: Mechanism of catalysis, J. Biol. Chem. 252:732–738.
Lewis, A. S., and Glantz, M. D., 1976, Monomeric purine nucleoside Phosphorylase from rabbit liver: Purification and characterization, J. Biol. Chem. 251:407–413.
Lum, C. T., Sutherland, D. E. R., and Najarian, J. D., 1977, Inhibition for immunosuppression, N. Engl. J. Med. 296:819.
Malawista, S. E., 1977, Gouty inflammation, Arthritis Rheum, (in press).
Mandel, N. S., 1976, The structural basis of crystal-induced membranolysis, Arthritis Rheum. 19:439–445.
Mandel, N. S., and Mandel, G. S., 1976, Monosodium urate monohydrate, the gout culprit, J. Am. Chem. Soc. 98:2319–2323.
Mangoff, S. C., and Milner, J. A., 1977, Oxonate induced uricosuria and orotic aciduria in mice, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36:1117 (abstract).
Manzke, H., 1976, Variable Expressivität der Genwirkung beim Lesch-Nyhan Syndrom, Deutsch. Med. Wochenschr. 101:428–429.
Martin, D., 1977, (peronal communication).
Martin, D. W., Jr., and Maler, B. A., 1976, Phosphoribosylpyrophosphate synthetase is elevated in fibroblasts from patients with the Lesch-Nyhan syndrome, Science 193:408–411.
McGuire, T. C., Pollara, B., Moore, J. J., and Poppie, M. J., 1976, Evaluation of adenosine deaminase and other purine salvage pathway enzymes in horses with combined immunodeficiency, Infect. Immun. 13:995–997.
McKeran, R. O., 1977, Factors in the pathogenesis of the brain damage and anaemia in the Lesch-Nyhan syndrome, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 83–96, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Meuwissen, H. J., Pickering, R. J., Pollara, B., and Porter, I. H., (eds.), 1975, Combined Immunodeficiency Disease and Adenosine Deaminase Deficiency: A Molecular Defect, Academic Press, New York.
Mills, G. C., Schmalstieg, F. C., Trimmer, K. B., Goldman, A. S., and Goldblum, R. M., 1976, Purine metabolism in adenosine deaminase deficiency, Proc. Natl. Acad. Sci. U.S.A. 73:2867–2871.
Milman, G., Anton, D. L., and Weber, J. L., 1976a, Chinese hamster purine-nucleoside Phosphorylase: Purification, structural and catalytic properties, Biochemistry 15:4967–4973.
Milman, G., Lee, E., Gurdev, S.-G., McLaughlin, J. R., and George, M., Jr., 1976b, Analysis of HeLa cell hypoxanthine phosphoribosyltransferase mutants and revertants by two-dimensional Polyacrylamide gel electrophoresis: Evidence for silent gene activation, Proc. Natl. Acad. Sci. U.S.A. 73:4589–4593.
Milner, J. A., Prior, R. L., and Visek, W. J., 1975, Arginine deficiency and orotic aciduria in mammals, Proc. Soc. Exp. Biol. Med. 150:282–288.
Mizuno, T.-I., and Yugari, Y., 1974, Self mutilation in the Lesch-Nyhan syndrome, Lancet 1:761.
Morely, C. J., Houston, I. B., and Morris-Jones, P., 1976, Acute renal failure and gout as presenting features of acute lymphoblastic leukaemia, Arch. Dis. Child. 51:723–725.
MĂĽller, M. M., Kaiser, E., and Seegmiller, J. E. (eds.), 1977a, Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects, Plenum Press, New York, 641 pp.
MĂĽller, M. M., Kaiser, E., and Seegmiller, J. E. (eds.), 1977b, Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects, Plenum Press, New York, 373 pp.
Newcombe, D. S., 1975, Inherited Biochemical Disorders and Uric Acid Metabolism, University Park Press, Baltimore, 282 pp.
Nishida, Y., Akaoka, I., Nishizawa, T., Maruki, M., Aikawa, T., Mitamura, T., Yokohari, R., and Horiuchi, Y., 1976, A case of gouty arthritis associated with Down’s syndrome, J. Ment. Defic. Res. 20:277–283.
Nishizawa, T., Nishida, Y., Akaoka, I., and Yoshimura, T., 1975, Erythrocyte adenosine deaminase and purine nucleoside Phosphorylase activity in gout, Clin. Chim. Acta 58:277–282.
Nishizawa, T., Nishida, Y., and Akaoka, I., 1976, Erythrocyte adenosine kinase activity in gout, Clin. Chim. Acta 67:15–20.
Nuki, G., Astrin, K., Brenton, D., Cruikshank, M., Lever, J., and Seegmiller, J. E., 1977a, Purine and pyrimidine nucleotides in some mutant human lymphoblasts, in: Ciba. Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 127–142, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Nuki, G., Astrin, K., Brenton, D., Cruikshank, M., Lever, J., and Seegmiller, J. E., 1977b, Purine and pyrimidine nucleotide concentrations in cells with decreased hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 326–340, Plenum Press, New York.
Nyhan, W. L., 1976, Behavior in the Lesch-Nyhan syndrome, J. Autism Child. Schizophr. 6:235–252.
Nyhan, W. L., 1977, Genetic heterogeneity at the locus for hypoxanthine-guanine phosphoribosyltransferase, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 65–82, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
O’Dorisio, M. S., Neidhart, J. A., Daniel, F. B., Balcerzak, S. P., and LoBuglio, A. F., 1976, Identification of hypoxanthine as the major component of a chromatographic fraction of transfer factor, Cell. Immunol. 23:191–202.
Parkman, R., Gelfand, E. W., Rosen, F. S., Sanderson, A., and Hirschhorn, R., 1975, Severe combined immunodeficiency and adenosine deaminase deficiency, N. Engl. J. Med. 292:714–719.
Pasero, G., 1977, Recurrent gouty phlebitis without articular gout, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 245–248, Plenum Press, New York.
Planet, G., and Fox, I. H., 1976, Inhibition of phosphoribosylpyrophosphate synthesis by purine nucleosides in human erythrocytes, J. Biol. Chem. 251:5839–5844.
Polmar, S. H., 1977, Enzyme replacement with red cells, N. Engl. J. Med. 296:943.
Polmar, S. H., Wetzler, E. M., Stern, R. C., and Hirschhorn, R., 1975, Restoration of in vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency, Lancet 2:743–746.
Polmar, S. H., Stern, R. C., Schwartz, A. L., Wetzler, E. M., Chase, P. A., and Hirschhorn, R., 1976, Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency, N. Engl. J. Med. 295:1337–1343.
Pritchard, J. B., O’Connor, N., Oliver, J. M., and Berlin, R. D., 1975, Uptake and supply of purine compounds by the liver, Am. J. Physiol. 229:967–972.
Quagliata, F., Faig, D., Conklyn, M., and Silber, R., 1974, Studies on the lymphocyte 5-nucleotidase in chronic lymphocytic leukemia, infectious mononucleosis, normal subpopulations, and phytohemagglutinin-stimulated cells, Cancer Res. 34:3197–3202.
Quinlan, D. C., and Hochstadt, J., 1976, Group translocation of the ribose moiety of inosine by vesicles of plasma membrane from 3T3 cells transformed by simian virus 40, J. Biol. Chem. 251:344–354.
Raivio, K. O., and Hovi, T., 1977, Adenine and adenosine metabolism in phyto-chemagglutinin(PHA)-stimulated normal human lymphocytes, in: Advances in Experimental Medicine and Biology, Vol. 76 A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds), pp. 448–455, Plenum Press, New York.
Raivio, K. O., Schwartz, A. L., Stern, R. C., and Polmar, S. H., 1977, Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase activity, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 456–462, Plenum Press, New York.
Rapaport, E., and Zamecnik, P. C., 1976a, Incorporation of adenosine into ATP: Formation of compartmentalized ATP, Proc. Natl. Acad. Sci. U.S.A. 73:3122–3125.
Rapaport, E., and Zamecnik, P. C., 1976b, Presence of diadenosine 5′,5″′-P1.P4-tetraphosphate (Ap4A) in mammalian cells in levels varying widely with proliferative activity of the tissue: A possible positive “pleiotypic activator,” Proc. Natl. Acad. Sci. U.S.A. 73:3984–3988.
Reem, G. H., 1975, Phosphoribosylpyrophosphate overproduction, a new metabolic abnormality in the Lesch-Nyhan syndrome, Science 190:1098–1099.
Rieselbach, R. E., 1977, Renal handling of uric acid, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 1–22, Plenum Press, New York.
Rieselbach, R. E., and Steele, T. H. (eds.), 1975, Symposium on influence of the kidney upon urate homeostasis in man, Nephron 14:5–99.
Robins, R. K., 1975, Nucleosides and nucleotides: Past, present and future, Ann. N. Y. Acad. Sci. 255:597–610.
Rochant, H., Dreyfus, B., Rosa, R., and Boiron, M., 1975, First case of pyrimidine 5′-nucleotidase deficiency in a male, International Society of Hematology, Europe and Africa, Third Meeting, London, August 24–28, p. 19 (abstract).
Roe, T. F., and Kogut, M. D., 1977, The pathogenesis of hyperuricemia in glycogen storage disease, Type 1, Pediatr. Res. 11:664–669.
Rosen, F. S., 1977 (personal communication).
Rosenbloom, F. M., Henderson, J. F., Caldwell, I. C., Kelley, W. N., and Seegmiller, J. E., 1968, Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyl-transferase, J. Biol Chem. 243:1166–1173.
Roth, J. A., Breakefield, X. O., and Castiglione, C. M., 1976, Monoamine oxidase and catechol-O-methyltransferase activities in cultured human skin fibroblasts, Life Sci. 19:1705–1710.
Salti, I. S., Kattuah, N., Alam, S., Wehby, V., and Frayha, R., 1976, The effect of allopurinol on oxypurine excretion in xanthinuria, J. Rheum. 3:201–204.
Sartorelli, A. C., and Johns, D. G. (eds.), 1975, Antineoplastic and Immunosuppressive Agents, Vols. I and II, Springer-Verlag, New York—Heidelberg—Berlin.
Schmalstieg, F. C., Goldman, A. S., Mills, G. C., Monahan, T. M., Nelson, J. A., and Goldblum, R. M., 1976, Nucleotide metabolism in adenosine deaminase deficiency, Pediatr. Res. 10:393 (abstract).
Schmalstieg, F. C., Nelson, J. A., Mills, G. C., Monahan, T. M., Goldman, A. S., and Goldblum, R. M., 1977, Purine nucleotides in ADA-deficient lymphocytes, J. Pediatr. 91:48–51.
Schneider, W., Morgenstern, E., and Schindera, I., 1976, Lesch-Nyhan Syndrom ohne Selbstverstümmelungstendenz: Biochemische and morphologische Untersuchungen an Blutzellen eines Patienten, Deutsch. Med. Wochenschr. 101:167–172.
Schrader, W. P., Stacy, A. R., and Pollara, B., 1976, Purification of human erythrocyte adenosine deaminase by affinity column chromatography, J. Biol. Chem. 251:4026–4032.
Schultz, V., and Lowenstein, J. M., 1976, Purine nucleotide cycle, J. Biol. Chem. 251:485–492.
Schumacher, H. R., 1977, Bullous tophi in gout, Ann. Rheum. Dis. 36:91–93.
Scott, J. T., Sturge, R. A., Kennedy, A. C., Hart, D. P., and Buchanan, W. W., 1977, Serum uric acid levels in England and Scotland, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 214–222, Plenum Press, New York.
Seegmiller, J. E., 1974, Diseases of purine and pyrimidine metabolism, in: Duncan’s Diseases of Metabolism (P. K. Bondy and L. E. Rosenberg, eds.), pp. 655–774, W. B. Saunders Co., Philadelphia.
Seegmiller, J. E., 1976a, Disorders of purine and pyrimidine metabolism, in: The Year in Metabolism 1975–1976 (N. Freinkel, ed.), Chapt. 8, pp. 213–258, Plenum Press, New York.
Seegmiller, J. E., 1976b, Genetic defects in human purine metabolism leading to urolithiasis, International Symposium on Urolithiasis Research, Davos, Switzerland, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 147–154, Plenum Press, New York.
Seegmiller, J. E., 1976c, Inherited deficiency of hypoxanthine-guanine phosphori-bosyltransferase in X-linked uric aciduria (the Lesch-Nyhan syndrome and its variants), in: Advances in Human Genetics (H. Harris and K. Hirschhorn, eds.), pp. 75–163, Plenum Press, New York.
Seegmiller, J. E., Watanabe, T., and Schreier, M. H., 1977a, The effect of adenosine on lymphoid cell proliferation and antibody formation, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 249–266, Elsevier/ Excerpta Medica and North-Holland; Amsterdam and New York.
Seegmiller, J. E., Watanabe, T., Schreier, M. H., and Waldmann, T. A., 1977b, Immunological aspects of purine metabolism, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 412–433, Plenum Press, New York.
Sekiguchi, T., and Sekiguchi, F., 1973, Interallelic complementation in hybrid cells derived from Chinese hamster diploid clones deficient in hypoxanthine-guanine phosphoribosyl-transferase activity, Exp. Cell Res. 77:391–403.
Sekiguchi, T., Sekiguchi, F., and Tomii, S., 1974, Complementation in hybrid cells derived from mutagen-induced mouse clones deficient in hypoxanthine-guanine phosphoribosyltransferase activity, Exp. Cell Res. 88:410–414.
Sekiguchi, T., Sekiguchi, F., and Tomii, S., 1975a, Genetic complementation in hybrid cells derived from mutagen-induced mouse clones deficient in HGPRT activity, Exp. Cell Res. 93:207–218.
Sekiguchi, T., Sekiguchi, F., Tachibana, T., Yamada, T., and Yoshida, M., 1975b, Gene expression of foreign metaphase chromosomes introduced into cultured mammalian cells, Exp. Cell Res. 94:327–338.
Shenoy, T. S., and Clifford, A. J., 1975, Adenine nucleotide metabolism in relation to purine enzymes in liver, erythrocytes and cultured fibroblasts, Biochim. Biophys. Acta 411:133–143.
Siegal, F. P., Siegal, M., and Good, R. A., 1976, Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients, J. Clin. Invest. 58:109–122.
Siegenbeek van Heukelom, L. H., Staal, G. E. J., Stoop, J. W., and Zegers, B.J. M., 1976, An abnormal form of purine nucleoside Phosphorylase in a family with a child with severe defective T-cell and normal B-cell immunity, Clin. Chim. Acta 72:117–124.
Siegenbeek van Heukelom, L. H., Akkerman, J. W. N., Staal, G. E. J., deBruyn, C. H. M. M., Stoop, J. W., Zegers, B. J. M., deBree, P. K., and Wadman, S. K., 1977, A patient with purine nucleoside Phosphorylase deficiency: Enzymological and metabolic aspects, Clin. Chim. Acta 74:271–279.
Siess, E. A., and Wieland, O. H., 1976, Phosphorylation state of cytosolic and mitochondrial adenine nucleotides and of pyruvate dehydrogenase in isolated rat liver cells, Biochem. J. 156:91–102.
Simkin, P. A., 1977a, Role of local factors in the precipitation of urate crystals, in: Uric Acid: Handbook of Experimental Pharmacology (B. Kelley and I. M. Weiner, eds.),: Springer-Verlag, Heidelberg (in press).
Simkin, P. A., 1977b, The pathogenesis of podagra, Ann. Intern. Med. 86:230–233.
Simmonds, H. A., Van Acker, K.J., Cameron, J. S., and Snedden, W., 1976, The identification of 2,8-dihydroxyadenine, a new component of urinary stones, Biochem. J. 157:485–487.
Simmonds, H. A., Van Acker, K. J., Cameron, J. S., and McBurney, A., 1977, Purine excretion in complete adenine phosphoribosyltransferase deficiency: Effect on diet and allopurional therapy, in: Advance in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 304–311, Plenum Press, New York.
Skaper, S. D., and Seegmiller, J. E., 1976, Hypoxanthine-guanine phosphoribosyltransferase mutant glioma cells: Diminished monoamine oxidase activity, Science 194:1171–1173.
Skosey, J. L., Kozin, F., and Ginsberg, M., 1977, Protein adsorption to monosodium urate crystals: Differential responses of human peripheral blood neutrophils, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 209–213, Plenum Press, New York.
Snyder, F. F., and Seegmiller, J. E., 1976, The adenosine-like effect of exogenous cyclic AMP upon nucleotide and PP-ribose-P concentrations of cultured human lymphoblasts, FEBS Lett. 66:102–106.
Snyder, F. F., and Seegmiller, J. E., 1977 (unpublished observation).
Snyder, F. F., Mendelsohn, J., and Seegmiller, J. E., 1976, Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes, J. Clin. Invest. 58:654–666.
Snyder, F. F., Hershfield, M. S., and Seegmiller, J. E., 1977a, Purine toxicity in human lymphoblasts, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 30–39, Plenum Press, New York.
Snyder, F. F., Mendelsohn, J., and Seegmiller, J. E., 1977b, Adenosine and guanosine metabolism during phytohemagglutinin-induced transfromation of human lymphocytes, in: Advances in Experimental Medicine and Biology, Vol. 76 A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 441–447, Plenum Press, New York.
Sperling, O., Boer, P., Brosh, S., Zoref, E., and deVries, A., 1977a, Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and gout, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 143–164, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Sperling, O., Boer, P., Lipstein, B., Kupfer, B., Brosh, S., Zoref, E., Bashkin, P., and deVries, A., 1977b, Regulation of de novo purine synthesis in human and rat tissue: Role of oxidative pentose phosphate pathway activity and of ribose-5-phosphate and phosphoribosylpyrophosphate availability, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 481–487, Plenum Press, New York.
Spilberg, I., Gallacher, A., Mehta, J. M., and Mandell, B., 1976, Urate crystal-induced chemotactic factor: Isolation and partial characterization, J. Clin. Invest 58:815–819.
Stoop, J. W., Eijsvoogel, V. P., Zegers, B. J. M., Blok-Schut, B., van Bekkum, D. W., and Ballieux, R. E., 1976, Selective severe cellular immunodeficiency: Effect of thymus transplantation and transfer factor administration, Clin. Immunol. Immunopathol. 6:289–298.
Stoop, J. W., Zegers, B.J. M., Hendricks, G. F. M., Siegenbeekvan Heukelom, L. H., Staal, G. E. J., de Bree, P. K., Wadman, S. K., and Ballieux, R. E., 1977, Purine nucleoside Phosphorylase deficiency associated with selective cellular immunodeficiency, N. Engl. J. Med. 296:651–655.
Stuhlsatz, H. W., Enzensberger, W., and Greiling, H., 1977, Influence of urate on connective tissue metabolism, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 195–200, Plenum Press, New York.
Sturge, R. A., Scott, J. T., Hamilton, E. B. D., Liyanage, S. P., St. J. Dixon, A., and Engler, C., 1977, Multi-centre trial of naproxen and phenylbutazone in acute gout, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 290–296, Plenum Press, New York.
Sweetman, L., Borden, M., Lesch, P., Bakay, B., and Becker, M. A., 1977a, Diminished affinity for purine substrates as a basis for gout with mild deficiency of hypoxanthine-guanine phosphoribosyltransferase, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 319–325, Plenum Press, New York.
Sweetman, L., Borden, M., Kulovich, S., Kaufman, I., and Nyhan, W. L., 1977b, Altered excretion of 5-hydroxyindoleacetic acid and glycine in patients with the Lesch-Nyhan disease, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 398–404, Plenum Press, New York.
Takkunen, H., and Reunanen, A., 1977, Hyperuricemia and other cardiovascular risk factors, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 238–244, Plenum Press, New York.
Talbott, J. H., and YĂĽ, T.-F., 1976, Gout and Uric Acid Metabolism, Stratton Intercontinental Medical Book Corp., New York, 303 pp.
Treuman, T. M., and Glantz, M. D., 1977, Isolation, purification and subunit structure of rabbit liver purine nucleoside Phosphorylase, Fed. Proc. Fed. Am. Soc. Exp. Biol. 36:873 (abstract).
Trotta, P. P., Smithwick, E. M., and Balis, M. E., 1976, A normal level of adenosine deaminase activity in the red cell lysates of carriers and patients with severe combined immunodeficiency disease, Proc. Natl. Acad. Sci. U.S.A. 73:104–108.
Ullman, B., Cohen, A., and Martin, D. W., Jr., 1976, Characterization of a cell culture model for the study of adenosine deaminase and purine nucleoside phosphorylase-deficient immunologic disease, Cell 9:205–211.
Upchurch, K. S., Leyva, A., Arnold, W. j., Holmes, E. W., and Kelley, W. N., 1975, Hypoxanthine phosphoribosyltransferase deficiency: Association of reduced catalytic activity with reduced levels of immunologically detectable enzyme protein, Proc. Natl. Acad. Sci. U.S.A. 72:4142–4146.
Valentine, W. N., Paglia, D. E., Fink, K., and Madokoro, G., 1976, Lead poisoning: Association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine5′-nucleotidase deficiency, and intraerythrocyte accumulation of pyrimidine, J. Clin. Invest. 58:926–932.
Valentine, W. N., Paglia, D. E., Tartaglia, A. P., and Gilsanz, F., 1977, Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate, Science 195:783–785.
Van Acker, K. J., Simmonds, H. A., and Cameron, J. S., 1977, Complete deficiency of adenine phosphoribosyltransferase: Report of a family, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 295–302, Plenum Press, New York.
Vanderheiden, B. S., 1969, Genetic studies of human erythrocyte inosine triphosphatase, Biochem. Genet. 3:289–297.
Vanderheiden, B. S., 1976, Erythrocyte ITP pyrophosphohydrolase deficiency in a psychiatric population, Biol. Psychiatry 11:755–765.
Van der Weyden, M. B., and Kelley, W. N., 1976, Human adenosine deaminase: Distribution and properties, J. Biol. Chem. 251:5448–5456.
Van der Weyden, M. B., Buckley, R. H., and Kelley, W. N., 1974, Molecular form of adenosine deaminase in severe combined immunodeficiency, Biochem. Biophys. Res. Common. 57:590–595.
van Herwaarden, C. L., van der Korst, J. K., Boerbooms, A. M., de Bruyn, C. H., and Oei, T. L., 1976, Partial hypoxanthine-guanine phosphoribosyltransferase deficiency in a “Celebesian” family: A case of crippling gout associated with haematological disorders, Neth.f. Med. 19:272–278.
Van Reen, R. (ed.), 1977, Proceedings of the WHO Regional Symposium on Vesical Calculus Disease (1972), NIAMDD DHEW Publ. No. (NIH) 77–1191, 281 pp.
Vives-Corrons, J. L., Montserrat-Costa, E., Pujades, A., Woessner, S., and Rozman, C., 1976a, Congenital erythrocytic pyrimidine 5′-nucleotidase deficiency: A new type of haemolytic erythro-enzymopathy (author’s transl.), Sangre 21:827–835.
Vives-Corrons, J. L., Montserrat-Costa, E., and Rozman, C., 1976b, Hereditary hemolytic anemia with erythrocyte pyrimidine 5′-nucleotidase deficiency in Spain: Clinical, biological and familial studies, Hum. Genet. 34:285–292.
Wadman, S. K., de Bree, P. K., van Gennip, A. H., Stoop, J. W., Zegers, B.J. M., Staal, G. E. J., and Siegenbeek van Heukelom, L. H., 1976, Urinary purines in a patient with a severely defective T cell immunity and a purine nucleoside Phosphorylase deficiency, Adv. Exp. Med. Biol. 76A:471.
Wadman, S. K., de Bree, P. K., van Gennip, A. H., Stoop, J. W., Zegers, B.J. M., Staal, G. E. J., and Siegenbeek van Heukelom, L. H., 1977, Urinary purines in a patient with a severely defective T cell immunity and a purine nucleoside Phosphorylase deficiency, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 471–476, Plenum Press, New York.
Waldmann, T. A., and Broder, S., 1977, Suppressor cells in the regulation of the immune response, in: Progress in Clinical Immunology, Vol. III (R. S. Schwartz. ed.), pp. 155–199, Grune & Stratton, New York.
Waldmann, T. A., Durm, M., Broder, S., Blackman, M., Blaese, R. M., and Strober, W., 1974, Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinemia, Lancet 2:609–613.
Watts, R. W. E., 1976, Uric acid biosynthesis and its disorders, J. R. Coll. Physicians London 11:91–106.
Webster, A. D. B., and Asherson, G. L., 1974, Identification and function of T cells in the peripheral blood of patients with hypogammaglobulinemia, Clin. Exp. Immunol. 18:499–504.
Wolberg, G., Zimmerman, T. P., Hiemstra, K., Winston, M., and Chu, L.-C., 1975, Adenosine inhibition of lymphocyte-mediated cytolysis: Possible role of cyclic adenosine monophosphate, Science 187:957–959.
Wolf, J. W., Anderson, J. A., Reid, R. H., Weiss, L., and Lightbody, J. J., 1976, Syndrome of cellular immunodeficiency with immunoglobulins associated with adenosine deaminase deficiency, Pediatr. Res. 10:394 (abstract).
Wyngaarden, J. B., 1976, Regulation of purine biosynthesis and turnover, Adv. Enzyme Regul. 14:25–42.
Wyngaarden, J. B., and Holmes, E. W., Jr., 1977, Molecular nature of enzyme regulation in purine biosynthesis, in: Ciba Found. Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 43–64, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Wyngaarden, J. B., and Kelley, W. N., 1976, Gout and Hyperuricemia, Grune & Stratton, New York.
Yü, T. F., 1977, Some unusual features of gouty arthritis in females, Semin. Arthritis Rheum. 6:247–255.
Yuh, K.-C. M., and Tao, M., 1974, Purification and characterization of adenosine-adenosine cyclic 3′,5′-monophosphate binding protein factors from rabbit erythrocytes, Biochemistry 13:5220–5226.
Zannis, V., Doyle, D., and Martin, D. W., Jr., 1977a, Purification and characterization of human erythrocyte purine nucleoside Phosphorylase and its subunits, J. Biol. Chem. (in press).
Zannis, V. I., Gudas, L. J., Doyle, D., and Martin, D. W., Jr., 1977b, Purification and characterization of hypoxanthine-guanine phosphoribosyl transferase from cultured HTC cells, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 162–171, Plenum Press, New York.
Zimmer, H.-G., and Gerlach, E., 1977, Studies on the regulation of the biosynthesis of myocardial adenine nucleotides, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 40–49, Plenum Press, New York.
Zöllner, N., and Gröbner, W., 1977, Dietary feedback regulation of purine and pyrimidine biosynthesis in man, in: Ciba Foundation Symp. No. 48: Purine and Pyrimidine Metabolism, pp. 165–178, Elsevier/Excerpta Medica and North-Holland, Amsterdam and New York.
Zöllner, N., Gröbner, W., and Rauch-Janssen, A., 1977, The effect of different purines and pyrimidines on human pyrimidine biosynthesis, in: Advances in Experimental Medicine and Biology, Vol. 76B, Purine Metabolism in Man II: Physiology, Pharmacology, and Clinical Aspects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 269–273, Plenum Press, New York.
Zoref, E., deVries, A., and Sperling, O., 1977a, Transfer of resistance to selective conditions from fiborblasts with mutant feedback-resistant phosphoribosylpy-rophosphate snythetase to normal cells: A form of metabolic cooperation, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 80–84, Plenum Press, New York.
Zoref, E., deVries, A., and Sperling, O., 1977b, X-linked pattern of inheritance of gout due to mutant feedback-resistant phosphoribosylpyrophosphate synthetase, in: Advances in Experimental Medicine and Biology, Vol. 76A, Purine Metabolism in Man II: Regulation of Pathways and Enzyme Defects (M. M. Müller, E. Kaiser, and J. E. Seegmiller, eds.), pp. 287–292, Plenum Press, New York.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Publishing Corporation
About this chapter
Cite this chapter
Seegmiller, J.E. (1978). Disorders of Purine and Pyrimidine Metabolism. In: Freinkel, N. (eds) The Year in Metabolism 1977. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2499-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2499-7_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2501-7
Online ISBN: 978-1-4684-2499-7
eBook Packages: Springer Book Archive